The use of the PD-1/PD-L1 pathway as an immunotherapy in oncological diseases, autoimmune diseases and infectious diseases

The use of the PD-1/PD-L1 pathway as an immunotherapy in oncological diseases, autoimmune diseases and infectious diseases

<p dir="ltr"><strong>Introduction: </strong></p><p dir="ltr"><strong></strong>PD-1 is programmed death receptor 1 belonging to the CD28 family of receptors. Immune cells have this receptor on their surface. PD-L1 allows cancer cells to av...

Full description

Bibliographic Details
Main Authors: Dominika Katarzyna Madras, Agata Agnieszka Rocka, Klaudia Daria Szumna, Patryk Piotr Jasielski, Faustyna Piędel
Format: Article
Language:English
Published: Kazimierz Wielki University 2020-04-01
Series:Journal of Education, Health and Sport
Subjects:
programmed death receptor-1 (pd-1)
programmed death receptor ligand-1 (pd-l1)
immunotherapy
oncology
autoimmunology
infectious diseases
Online Access:https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/29711

Internet

https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/29711

Similar Items